∘₊✧──────✧₊∘∘₊✧──────✧₊∘∘₊
Foundation Personnel Database
Personnel Designation: Dr. Selene Kazan
Security Clearance: Level 4
Department: Toxicology Division
Current Assignment: Site-17
Position: Head of Toxicology
Full Name: Dr. Selene Kazan
Date of Birth: February 15, 1989
Place of Birth: Kalamata, Greece
Nationality: Greek-American
Languages: Greek (Native), English (Fluent)
Height: 152.4 cm (5 ft 0 in)
Weight: 40.37 kg (89 lbs)
Dr. Selene Kazan was born in Kalamata, Greece, as the only child of Adonis and Lenora Kazan. Her father, a professional chemist, frequently conducted experiments within a private laboratory attached to the family residence. Exposure to advanced chemistry from an early age fostered an exceptional aptitude for toxicology, pharmacology, and organic chemistry.
Foundation psychological evaluations indicate that Dr. Kazan experienced a childhood marked by persistent emotional neglect. Reports describe an environment characterized by unrealistic academic expectations from her father and emotional detachment from her mother. As a result, Dr. Kazan developed chronic anxiety and significant social withdrawal during adolescence.
By the age of sixteen, Dr. Kazan had independently mastered numerous historical and modern methods of synthesizing toxic compounds. While these activities were initially recreational, they later developed into legitimate scientific research focused on antidotes, biochemical interactions, and venom derivatives.
At age twenty-one, Dr. Kazan emigrated to the United States to pursue research opportunities unavailable in Greece. Foundation surveillance programs monitoring anomalous chemical research identified several experimental compounds developed by Dr. Kazan that demonstrated unusual biochemical properties not achievable through conventional chemistry.
Following an extensive background investigation, Dr. Kazan was approached by Foundation recruiters. She accepted employment after reviewing Foundation research objectives involving anomalous toxicological substances and was assigned to Site-17.
Within five years, Dr. Kazan was promoted to Head of Toxicology, overseeing all research involving anomalous venoms, toxins, corrosive compounds, biochemical counteragents, and anti-toxic pharmaceuticals.
* Pharmaceutical Development
* Chemical Weapon Neutralization
* SCP Biological Hazard Analysis
* Anomalous Compound Stabilization
Psychological Evaluation Summary
Lead Evaluator: Dr. Simon Glass
Evaluation Status: Ongoing
Dr. Kazan demonstrates exceptional analytical reasoning, remarkable patience within laboratory environments, and meticulous attention to detail. Her cognitive abilities consistently rank among the highest recorded within Site-17’s research divisions.
Despite these strengths, Dr. Kazan exhibits pronounced social anxiety and tends to avoid unnecessary interpersonal interactions. She is significantly more comfortable communicating through written reports than verbal discussion.
She frequently overworks herself, often remaining in laboratory environments for periods exceeding twenty consecutive hours without adequate sleep or meals. Intervention by Site personnel has become routine.
While emotionally reserved, Dr. Kazan has shown genuine compassion toward junior researchers and personnel under her supervision. She consistently advocates for safety protocols and has repeatedly delayed experimentation when unnecessary risks to staff were identified.
Her anxiety manifests primarily through perfectionism and self-imposed expectations rather than outward emotional displays.
Recommendation: Continue quarterly counseling sessions. Mandatory meal and rest reminders remain in effect.
* Carries multiple emergency antidote injectors on her person at all times.
* Maintains a private notebook containing thousands of handwritten toxicological formulas.
* Frequently mutters calculations in Greek while working.
* Displays noticeably improved focus when classical music is playing in the laboratory.
* Known to unintentionally lose track of time during research.
* Laboratory staff have unofficially nicknamed her “The Poison Queen.” Dr. Kazan has repeatedly requested the nickname not be used in official documentation.
* Developed twenty-three Foundation-standard antidotes for previously untreatable anomalous toxins.
* Successfully stabilized the first long-term storage solution for multiple anomalous venom samples.
* Reduced Site-17 laboratory exposure incidents by 61% following implementation of revised containment procedures.
* Received the Foundation Award for Scientific Excellence on two separate occasions.
Disciplinary Actions: None.
Containment Breaches Directly Attributed: None.
* Minor chemical exposure (x4)
* Self-administered antidote following accidental venom injection (x2)
* Extended sleep deprivation requiring mandatory medical leave (x6)
“Dr. Kazan possesses one of the sharpest scientific minds I’ve encountered. Her work has undoubtedly saved lives, both Foundation personnel and civilians alike. Unfortunately, she treats herself with considerably less care than she affords everyone else. Left unsupervised, she would happily spend days inside her laboratory until exhaustion forced her to stop. She remains one of Site-17’s greatest assets—and one of its greatest concerns.”
— Site-17 Director’s Annual Personnel Review
Although Dr. Kazan routinely handles substances capable of causing mass casualties if misused, no evidence of malicious intent has ever been observed.
Her personal ethics strongly emphasize the responsible application of science and the preservation of life. Foundation Internal Affairs has repeatedly reaffirmed its confidence in her reliability.
Personnel Risk Assessment: Low
Scientific Value Assessment: Exceptional
Overall Employment Recommendation: Continued unrestricted access to Site-17 toxicological laboratories under existing Level 4 security clearance.
titsay
tangentwithtanner
andulkaphoto
vaporwave
romaincrisis
2087
gracieabrams